TrialHaematologica2018

End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making.

Christopher Melani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.